Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Financial Statements and Exhibits

0

Simulations Plus, Inc. (NASDAQ:SLP) Files An 8-K Financial Statements and Exhibits
Item 9.01(a) and (b). This filing reports no other updates or amendments to the Original 8-K.

Item 9.01 Financial Statements and Exhibits.

(a)Financial Statements of Business Acquired.

(i) The audited financial statements of DILIsym Services, Inc., as of December 31, 2016 are filed as Exhibit 99.1 hereto.
(ii) The unaudited balance sheet of DILIsym Services, Inc. as of May 31, 2017 and the unaudited statements of operations for the five months ended May 31, 2017 and 2016 are filed as Exhibit 99.2 hereto.

(b)Pro Forma Financial Information.

The unaudited pro forma condensed combined balance sheet of the Company as of May 31, 2017, which gives effect to the acquisition of DILIsym Services, Inc., and the unaudited pro forma condensed combined statements of operations for the nine months ended May 31, 2017 and the year ended August 31, 2016, which give effect to such acquisition, are attached hereto as Exhibit 99.3 hereto.

(d)Exhibits

23.1 Consent of Dixon Hughes Goodman LLP.


SIMULATIONS PLUS INC Exhibit
EX-23.1 2 simulations_8ka-ex2301.htm CONSENT Exhibit 23.1     CONSENT OF INDEPENDENT AUDITOR     We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-142882,…
To view the full exhibit click here

About Simulations Plus, Inc. (NASDAQ:SLP)

Simulations Plus, Inc. (Simulations Plus) develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The Company offers five software products for pharmaceutical research. ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity) Predictor is a computer program that takes molecular structures as inputs and predicts over 140 different properties for them at the rate of about 200,000 compounds per hour. MedChem Designer includes a small set of ADMET Predictor property predictions, allowing the chemist to modify molecular structures. MedChem Studio is a tool for medicinal and computational chemists for both data mining and for designing new drug-like molecules. DDDPlus simulates in-vitro laboratory experiments used to measure the rate of dissolution of the drug. GastroPlus simulates the absorption, pharmacokinetics, and pharmacodynamics of drugs.